UNPARALLELED expertise

Dr. William (Bill) Hait, former EVP and Chief External Innovation and Medical Officer at Johnson & Johnson, brings decades of expertise in biomedical research and innovation.

William N. Hait, M.D., Ph.D., served as  Executive Vice President, Chief External Innovation, Medical Safety and Global Public Health Officer, and a member of the Johnson & Johnson Executive Committee.  In this role Dr. Hait was responsible for leading external sourcing and creation of transformational innovations that could change the trajectory of health for humanity. 

Prior to this role, Dr. Hait served as Global Head, Johnson & Johnson External Innovation, where he built an enterprise-wide external R&D pipeline, creating innovative solutions utilizing the Company’s excellence in pharmaceuticals, medical devices, and consumer products.  His team identified disruptive technologies and cutting-edge early innovations in disease areas of emphasis at Johnson & Johnson to eliminate disease through prevention, interception, and cures. 

Dr. Hait joined Johnson & Johnson in 2007 and served as Global Therapeutic Area Head for Oncology from 2009 to 2011, and then as Global Head, Janssen Research & Development, from 2011 through 2018 and again from 2022-2023.  Under his leadership, the company launched over 30 new products and line extensions, transforming the lives of millions of people around the world.

Before joining Johnson & Johnson, he was the founding Director of the (Rutgers) Cancer Institute of New Jersey.  From 1993 to 2007 he was Professor of Medicine and Pharmacology and Associate Dean for Oncology Programs at the University of Medicine and Dentistry of New Jersey -- Robert Wood Johnson Medical School.